Table 4.
Antibiotic susceptibility testing
| Gram type | Antibiotic | Sample type | S (%) | R (%) | I (%) | X 2 | p Value |
|---|---|---|---|---|---|---|---|
| Gram‐positive bacteria | Chloramphenicol | Wound samples | 21 (27) | 55 (71) | 3 (12) | 0.948 | 0.623 |
| Non‐wound sample | 19 (26) | 54 (73) | 1 (1) | ||||
| Clindamycin | Wound samples | 32 (41) | 37 (47) | 9 (12) | 2.632 | 0.268 | |
| Non‐wound sample | 19 (26) | 54 (73) | 1 (1) | ||||
| Ciprofloxacin | Wound samples | 21 (27) | 52 (67) | 5 (6) | 27.136 | 0.000 | |
| Non‐wound sample | 51 (69) | 20 (27) | 3 (4) | ||||
| Tetracycline | Wound samples | 12 (15) | 60 (77) | 6 (8) | 1.183 | 0.554 | |
| Non‐wound sample | 16 (22) | 54 (73) | 4 (5) | ||||
| Trimethoprim‐Sulfamethoxazole | Wound samples | 21 (27) | 50 (64) | 7 (9) | 3.840 | 0.147 | |
| Non‐wound sample | 31 (42) | 37 (50) | 6 (8) | ||||
| Erythromycin | Wound samples | 32 (41) | 37 (47) | 9 (12) | 29.292 | 0.000 | |
| Non‐wound sample | 39 (53) | 27 (36) | 8 (11) | ||||
| Gentamicin | Wound samples | 48 (62) | 22 (28) | 8 (10) | 24.293 | 0.000 | |
| Non‐wound sample | 48 (65) | 20 (27) | 6 (8) | ||||
| Penicillin | Wound samples | 17 (22) | 59 (76) | 2 (3) | 0.898 | 0.638 | |
| Non‐wound sample | 21 (28) | 51 (69) | 2 (3) | ||||
| Cefoxitin | Wound samples | 33 (42) | 43 (55) | 2 (3) | 7.114 | 0.029 | |
| Non‐wound sample | 47 (64) | 25 (34) | 2 (3) | ||||
| Gram‐negative bacteria | Ampicillin | Wound samples | 11 (25) | 3 (7) | 30 (68) | 1.011 | 0.603 |
| Non‐wound sample | 3 (23) | 0 (0) | 10 (77) | ||||
| Chloramphenicol | Wound samples | 9 (20) | 1 (2) | 34 (77) | 7.035 | 0.030 | |
| Non‐wound sample | 7 (54) | 1 (8) | 5 (38) | ||||
| Clindamycin | Wound samples | 17 (39) | 8 (18) | 19 (43) | 6.520 | 0.038 | |
| Non‐wound sample | 10 (77) | 0 (0) | 3 (23) | ||||
| Ciprofloxacin | Wound samples | 32 (73) | 3 (7) | 9 (20) | 3.227 | 0.199 | |
| Non‐wound sample | 6 (46) | 2 (15) | 5 (38) | ||||
| Amoxicillin | Wound samples | 15 (34) | 5 (11) | 24 (55) | 1.884 | 0.390 | |
| Non‐wound sample | 4 (31) | 0 (0) | 9 (69) | ||||
| Tetracycline | Wound samples | 17 (39) | 1 (2) | 26 (59) | 0.632 | 0.729 | |
| Non‐wound sample | 4 (31) | 0 (0) | 9 (69) | ||||
| Trimethoprim‐Sulfamethoxazole | Wound samples | 11 (25) | 7 (16) | 26 (59) | 2.288 | 0.319 | |
| Non‐wound sample | 6 (46) | 1 (8) | 6 (46) | ||||
| Gentamicin | Wound samples | 30 (68) | 3 (7) | 11 (25) | 1.015 | 0.602 | |
| Non‐wound sample | 9 (69) | 0 (0) | 4 (31) | ||||
| Ceftriaxone | Wound samples | 23 (52) | 8 (18) | 13 (30) | 0.957 | 0.620 | |
| Non‐wound sample | 7 (54) | 1 (8) | 5 (38) | ||||
| Cefuroxime | Wound samples | 14 (32) | 3 (7) | 27 (61) | 6.094 | 0.047 | |
| Non‐wound sample | 9 (69) | 0 (0) | 4 (31) | ||||
| Ceftazidime | Wound samples | 34 (77) | 3 (7) | 7 (16) | 3.583 | 0.167 | |
| Non‐wound sample | 13 (100) | 0 (0) | 0 (0) |